Lipid phosphate phosphatase-1 and Ca2+ control lysophosphatidate signaling through EDG-2 receptors

J Biol Chem. 2000 Sep 8;275(36):27520-30. doi: 10.1074/jbc.M003211200.

Abstract

The serum-derived phospholipid growth factor, lysophosphatidate (LPA), activates cells through the EDG family of G protein-coupled receptors. The present study investigated mechanisms by which dephosphorylation of exogenous LPA by lipid phosphate phosphatase-1 (LPP-1) controls cell signaling. Overexpressing LPP-1 decreased the net specific cell association of LPA with Rat2 fibroblasts by approximately 50% at 37 degrees C when less than 10% of LPA was dephosphorylated. This attenuated cell activation as indicated by diminished responses, including cAMP, Ca(2+), activation of phospholipase D and ERK, DNA synthesis, and cell division. Conversely, decreasing LPP-1 expression increased net LPA association, ERK stimulation, and DNA synthesis. Whereas changing LPP-1 expression did not alter the apparent K(d) and B(max) for LPA binding at 4 degrees C, increasing Ca(2+) from 0 to 50 micrometer increased the K(d) from 40 to 900 nm. Decreasing extracellular Ca(2+) from 1.8 mm to 10 micrometer increased LPA binding by 20-fold, shifting the threshold for ERK activation to the nanomolar range. Hence the Ca(2+) dependence of the apparent K(d) values explains the long-standing discrepancy of why micromolar LPA is often needed to activate cells at physiological Ca(2+) levels. In addition, the work demonstrates that LPP-1 can regulate specific LPA association with cells without significantly depleting bulk LPA concentrations in the extracellular medium. This identifies a novel mechanism for controlling EDG-2 receptor activation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.
  • Retracted Publication

MeSH terms

  • Animals
  • Calcium / metabolism
  • Calcium / pharmacology*
  • Calcium Signaling / physiology*
  • Cell Line
  • Cyclic AMP / metabolism
  • Fibroblasts
  • Green Fluorescent Proteins
  • Kinetics
  • Luminescent Proteins / analysis
  • Lysophospholipids / pharmacokinetics
  • Lysophospholipids / pharmacology*
  • Models, Biological
  • Nuclear Proteins / metabolism*
  • Oligodeoxyribonucleotides, Antisense / pharmacology
  • Phosphatidate Phosphatase / genetics
  • Phosphatidate Phosphatase / metabolism*
  • Phosphorylation
  • Rats
  • Receptors, Cell Surface*
  • Receptors, G-Protein-Coupled*
  • Receptors, Lysophosphatidic Acid
  • Recombinant Fusion Proteins / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / physiology*
  • Transcription Factors / metabolism*
  • Transfection
  • Zinc Fingers

Substances

  • Luminescent Proteins
  • Lysophospholipids
  • Nuclear Proteins
  • Oligodeoxyribonucleotides, Antisense
  • Receptors, Cell Surface
  • Receptors, G-Protein-Coupled
  • Receptors, Lysophosphatidic Acid
  • Recombinant Fusion Proteins
  • Transcription Factors
  • Green Fluorescent Proteins
  • Cyclic AMP
  • lipid phosphate phosphatase
  • Phosphatidate Phosphatase
  • Calcium